KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $175.9 million.

  • Exact Sciences' Accounts Payables rose 9634.26% to $175.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $175.9 million, marking a year-over-year increase of 9634.26%. This contributed to the annual value of $175.9 million for FY2025, which is 9634.26% up from last year.
  • According to the latest figures from Q4 2025, Exact Sciences' Accounts Payables is $175.9 million, which was up 9634.26% from $129.4 million recorded in Q3 2025.
  • Exact Sciences' Accounts Payables' 5-year high stood at $175.9 million during Q4 2025, with a 5-year trough of $34.7 million in Q1 2021.
  • Moreover, its 5-year median value for Accounts Payables was $75.0 million (2022), whereas its average is $84.5 million.
  • In the last 5 years, Exact Sciences' Accounts Payables crashed by 3023.19% in 2024 and then soared by 19694.98% in 2025.
  • Over the past 5 years, Exact Sciences' Accounts Payables (Quarter) stood at $67.8 million in 2021, then increased by 10.45% to $74.9 million in 2022, then increased by 5.21% to $78.8 million in 2023, then increased by 13.65% to $89.6 million in 2024, then soared by 96.34% to $175.9 million in 2025.
  • Its last three reported values are $175.9 million in Q4 2025, $129.4 million for Q3 2025, and $157.3 million during Q2 2025.